Compounds > naringenin

naringenin and Cardiac Hypertrophy

naringenin has been researched along with Cardiac Hypertrophy in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
He, B; He, Y; Li, Y; Xia, T; Zeng, C; Zhang, C1
Ding, S; Huang, B; Huang, J; Jiang, Q; Qiu, H; Wu, Q; Zhang, J1
Ding, S; Huang, B; Huang, J; Jiang, Q; Qiu, H; Zhang, J; Zhou, P1

Other Studies

3 other study(ies) available for naringenin and Cardiac Hypertrophy

ArticleYear
Naringenin Attenuates Isoprenaline-Induced Cardiac Hypertrophy by Suppressing Oxidative Stress through the AMPK/NOX2/MAPK Signaling Pathway.
    Nutrients, 2023, Mar-09, Volume: 15, Issue:6

    Topics: AMP-Activated Protein Kinases; Animals; Cardiomegaly; Isoproterenol; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Oxidative Stress; Signal Transduction

2023
Naringenin exhibits the protective effect on cardiac hypertrophy via EETs-PPARs activation in streptozocin-induced diabetic mice.
    Biochemical and biophysical research communications, 2018, 07-07, Volume: 502, Issue:1

    Topics: Animals; Cardiomegaly; Cardiotonic Agents; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Flavanones; Male; Myocardium; Peroxisome Proliferator-Activated Receptors; Up-Regulation

2018
EETs/PPARs activation together mediates the preventive effect of naringenin in high glucose-induced cardiomyocyte hypertrophy.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 109

    Topics: Animals; Atrial Natriuretic Factor; Cardiomegaly; Cell Line; Diabetic Cardiomyopathies; Flavanones; Glucose; Myocytes, Cardiac; PPAR gamma; Rats; RNA, Messenger; Signal Transduction; Up-Regulation

2019